EEG Alpha Power as an Intermediate Measure Between Brain-Derived Neurotrophic Factor Val66Met and Depression Severity in Patients With Major Depressive Disorder

Summary: Major depressive disorder has a large impact on patients and society and is projected to be the second greatest global burden of disease by 2020. The brain-derived neurotrophic factor (BDNF) gene is considered to be one of the important factors in the etiology of major depressive disorder. In a recent study, alpha power was found to mediate between BDNF Met and subclinical depressed mood. The current study looked at a population of patients with major depressive disorder (N = 107) to examine the association between the BDNF Val66Met polymorphism, resting state EEG alpha power, and depression severity. For this purpose, repeated-measures analysis of variance, partial correlation, and multiple linear models were used. Results indicated a negative association between parietal-occipital alpha power in the eyes open resting state and depression severity. In addition, Met/Met patients showed lower global absolute alpha power in the eyes closed condition compared with Val-carriers. These findings are in accordance with the previously uncovered pathway between BDNF Val66Met, resting state EEG alpha power, and depression severity. Additional research is needed for the clarification of this tentative pathway and its implication in personalized treatment of major depressive disorder.

[1]  D. Sheehan,et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.

[2]  E. Gordon,et al.  Integrative Neuroscience: The Role of a Standardized Database , 2005, Clinical EEG and neuroscience.

[3]  Eric J. Nestler,et al.  New approaches to antidepressant drug discovery: beyond monoamines , 2006, Nature Reviews Neuroscience.

[4]  Winfried Schlee,et al.  Top-Down Modulation of the Auditory Steady-State Response in a Task-Switch Paradigm , 2008, Front. Hum. Neurosci..

[5]  Juri D Kropotov,et al.  EEG Power Spectra at Early Stages of Depressive Disorders , 2009, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[6]  E Donchin,et al.  A new method for off-line removal of ocular artifact. , 1983, Electroencephalography and clinical neurophysiology.

[7]  David Goldman,et al.  Neurophysiological and genetic distinctions between pure and comorbid anxiety disorders , 2008, Depression and anxiety.

[8]  S. West,et al.  A comparison of methods to test mediation and other intervening variable effects. , 2002, Psychological methods.

[9]  M. Weissman,et al.  Electroencephalographic measures of regional hemispheric activity in offspring at risk for depressive disorders , 2005, Biological Psychiatry.

[10]  R. Duman,et al.  Serum Brain-Derived Neurotrophic Factor, Depression, and Antidepressant Medications: Meta-Analyses and Implications , 2008, Biological Psychiatry.

[11]  C. Shatz,et al.  Synaptic Activity and the Construction of Cortical Circuits , 1996, Science.

[12]  F. Vogel,et al.  The genetic basis of the normal human electroencephalogram (EEG) , 1970, Humangenetik.

[13]  Turan M. Itil,et al.  The discovery of antidepressant drugs by computer-analyzed human cerebral bio-electrical potentials (CEEG) , 1983, Progress in Neurobiology.

[14]  Xueying Jiang,et al.  BDNF Variation and Mood Disorders: A Novel Functional Promoter Polymorphism and Val66Met are Associated with Anxiety but Have Opposing Effects , 2005, Neuropsychopharmacology.

[15]  P. Schoenknecht,et al.  Hyperstable regulation of vigilance in patients with major depressive disorder , 2012, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[16]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[17]  T. Hergueta,et al.  The mini international neuropsychiatric interview , 1998, European Psychiatry.

[18]  E. Niedermeyer.  Alpha rhythms as physiological and abnormal phenomena. , 1997, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[19]  Gary H. Glover,et al.  Human Neuroscience , 2009 .

[20]  P. Sullivan,et al.  Genetic epidemiology of major depression: review and meta-analysis. , 2000, The American journal of psychiatry.

[21]  D. Ye,et al.  Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder , 2010, European Neuropsychopharmacology.

[22]  O. Wolkowitz,et al.  Serum BDNF levels before treatment predict SSRI response in depression , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[23]  J. Groves,et al.  Is it time to reassess the BDNF hypothesis of depression? , 2007, Molecular Psychiatry.

[24]  E. Castrén,et al.  Is mood chemistry? , 2005, Nature Reviews Neuroscience.

[25]  Gregor Thut,et al.  Resting electroencephalogram alpha-power over posterior sites indexes baseline visual cortex excitability , 2008, Neuroreport.

[26]  L. Schneider,et al.  Quantitative, waking EEG research on depression , 1990, Biological Psychiatry.

[27]  D. Kupfer,et al.  Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. , 2006, The American journal of psychiatry.

[28]  D I Boomsma,et al.  Heritability of human brain functioning as assessed by electroencephalography. , 1996, American journal of human genetics.

[29]  A. Rush,et al.  Maximizing the Adequacy of Medication Treatment in Controlled Trials and Clinical Practice: STAR*D Measurement-Based Care , 2007, Neuropsychopharmacology.

[30]  B. Penninx,et al.  Serum levels of brain-derived neurotrophic factor in major depressive disorder: state–trait issues, clinical features and pharmacological treatment , 2010, Molecular Psychiatry.

[31]  N. Akarsu,et al.  The effect of depression, BDNF gene val66met polymorphism and gender on serum BDNF levels , 2010, Brain Research Bulletin.

[32]  B. Baune,et al.  Brain-derived neurotrophic factor gene polymorphisms, neurotransmitter levels, and depressive symptoms in an elderly population , 2011, AGE.

[33]  C. Mathers,et al.  Projections of Global Mortality and Burden of Disease from 2002 to 2030 , 2006, PLoS medicine.

[34]  David Goldman,et al.  Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism , 2003, Psychiatric genetics.

[35]  B. Franke,et al.  Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity , 2010, Molecular Psychiatry.

[36]  D I Boomsma,et al.  Heritability of background EEG across the power spectrum. , 2005, Psychophysiology.

[37]  Marcus E Raichle,et al.  Intrinsic brain activity sets the stage for expression of motivated behavior , 2005, The Journal of comparative neurology.

[38]  P. Masand,et al.  An open-label, rater-blinded, flexible-dose, 8-week trial of escitalopram in patients with major depressive disorder with atypical features. , 2008, Primary care companion to the Journal of clinical psychiatry.

[39]  H. Kraemer,et al.  Predictors and moderators of time to remission of major depression with interpersonal psychotherapy and SSRI pharmacotherapy , 2010, Psychological Medicine.

[40]  Patrick J. McGrath,et al.  Electroencephalographic Alpha Measures Predict Therapeutic Response to a Selective Serotonin Reuptake Inhibitor Antidepressant: Pre- and Post-Treatment Findings , 2008, Biological Psychiatry.

[41]  M. Egan,et al.  The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function , 2003, Cell.

[42]  W. Herrmann,et al.  Association Analysis of Exonic Variants of the GABAB-Receptor Gene and Alpha Electroencephalogram Voltage in Normal Subjects and Alcohol-Dependent Patients , 2003, Behavior genetics.

[43]  Janet B W Williams,et al.  A structured interview guide for the Hamilton Depression Rating Scale. , 1988, Archives of general psychiatry.

[44]  R. Duman,et al.  A Neurotrophic Model for Stress-Related Mood Disorders , 2006, Biological Psychiatry.

[45]  Ludo Verhoeven,et al.  Different brain activation patterns in dyslexic children: evidence from EEG power and coherence patterns for the double-deficit theory of dyslexia. , 2007, Journal of integrative neuroscience.

[46]  Carol Dobson-Stone,et al.  Association between BDNF Val66Met polymorphism and trait depression is mediated via resting EEG alpha band activity , 2008, Biological Psychology.

[47]  W. Klimesch.  EEG alpha and theta oscillations reflect cognitive and memory performance: a review and analysis , 1999, Brain Research Reviews.

[48]  E. Gordon,et al.  An investigation of EEG, genetic and cognitive markers of treatment response to antidepressant medication in patients with major depressive disorder: a pilot study. , 2011, Journal of affective disorders.

[49]  S. Wisniewski,et al.  International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol , 2011, Trials.

[50]  I. Gottesman,et al.  The endophenotype concept in psychiatry: etymology and strategic intentions. , 2003, The American journal of psychiatry.